28.09
Schlusskurs vom Vortag:
$26.04
Offen:
$25.9
24-Stunden-Volumen:
330.48K
Relative Volume:
2.08
Marktkapitalisierung:
$263.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-2.7713
EPS:
-10.1344
Netto-Cashflow:
$-82.84M
1W Leistung:
+18.65%
1M Leistung:
+81.31%
6M Leistung:
+28.89%
1J Leistung:
-33.78%
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Vergleichen Sie KRRO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
KRRO
Korro Bio Inc
|
28.09 | 208.52M | 0 | -81.17M | -82.84M | -10.13 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
2024-08-14 | Eingeleitet | William Blair | Outperform |
2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
2019-10-28 | Eingeleitet | Cowen | Outperform |
2019-10-28 | Eingeleitet | Goldman | Buy |
2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Entry Recap: Does Korro Bio Inc. meet Warren Buffett’s criteriaBreakout Watch & Community Consensus Trade Alerts - khodrobank.com
Korro Bio reports Q2 EPS ($2.74), consensus ($2.59) - MSN
What’s the recovery path for long term holders of Korro Bio Inc.Analyst Upgrade & Technical Pattern Based Signals - Newser
Is Korro Bio Inc. stock risky to hold nowJuly 2025 Fed Impact & High Accuracy Swing Trade Signals - khodrobank.com
How high can Korro Bio Inc. stock go2025 Support & Resistance & Safe Entry Zone Tips - Newser
What candlestick patterns are forming on Korro Bio Inc.2025 Price Momentum & Reliable Entry Point Trade Alerts - Newser
Technical analysis overview for Korro Bio Inc. stock2025 Technical Overview & Real-Time Market Sentiment Alerts - Newser
Charles Schwab Investment Management Inc. Grows Stock Holdings in Korro Bio, Inc. $KRRO - Defense World
Ranking Korro Bio Inc. among high performing stocks via toolsTreasury Yields & Real-Time Stock Entry Alerts - Newser
Understanding Korro Bio Inc.’s price movementTrade Risk Assessment & Advanced Swing Trade Entry Plans - Newser
What dividend growth rate does Korro Bio Inc. offerJuly 2025 Opening Moves & Fast Gain Swing Alerts - khodrobank.com
Korro Bio Surges 20% in Volatile Session—What's Fueling the Momentum? - AInvest
Real time alert setup for Korro Bio Inc. performance2025 Year in Review & Stock Timing and Entry Methods - Newser
Korro Bio shares rise 4.30% intraday after announcing participation in upcoming investor and scientific conferences. - AInvest
Is Korro Bio Inc. still worth holding after the dipMarket Performance Report & Verified Momentum Watchlists - Newser
Identifying reversal signals in Korro Bio Inc.July 2025 Earnings & Safe Capital Growth Tips - Newser
Korro Bio Inc.’s volatility index tracking explainedEarnings Overview Report & AI Forecasted Entry and Exit Points - Newser
Tools to monitor Korro Bio Inc. recovery probabilityMarket Risk Report & Fast Gain Stock Trading Tips - Newser
What MACD and RSI say about Korro Bio Inc.2025 Year in Review & Low Risk High Reward Trade Ideas - Newser
What institutional flow reveals about Korro Bio Inc.Breakout Watch & Weekly Chart Analysis and Guides - Newser
Earnings visualization tools for Korro Bio Inc.July 2025 Movers & Daily Oversold Bounce Ideas - Newser
Resistance Check: Is Korro Bio Inc. stock a value trapEarnings Summary Report & Fast Moving Stock Trade Plans - khodrobank.com
Relative strength of Korro Bio Inc. in sector analysisMarket Trend Review & Daily Stock Momentum Reports - Newser
Leading RNA Editing Pioneer Korro Bio Takes Center Stage at 6 Major Healthcare & Scientific Conferences - Stock Titan
What the charts say about Korro Bio Inc. todayJuly 2025 Fed Impact & Consistent Profit Alerts - Newser
Is Korro Bio Inc. forming a bullish divergenceTrade Signal Summary & Weekly Stock Performance Updates - khodrobank.com
Korro Bio Inc. stock momentum explainedShare Buyback & Growth Focused Stock Reports - Newser
Is Korro Bio Inc. stock a hidden gem2025 Top Decliners & Comprehensive Market Scan Reports - khodrobank.com
Real time social sentiment graph for Korro Bio Inc.Weekly Risk Summary & AI Enhanced Trading Signals - Newser
Real time pattern detection on Korro Bio Inc. stockWeekly Trend Summary & Technical Entry and Exit Tips - Newser
Using portfolio simulators with Korro Bio Inc. included2025 Top Gainers & Free Technical Pattern Based Buy Signals - Newser
Will Korro Bio Inc. bounce back from current supportEarnings Overview Summary & Accurate Buy Signal Notifications - Newser
Using AI based signals to follow Korro Bio Inc.Market Activity Recap & Weekly Sector Rotation Insights - Newser
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
Korro Bio Inc-Aktie (KRRO) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):